News

Some Peripartum Cardiomyopathy Is Actually Familial Disease


 

FROM THE ANNUAL CONGRESS OF THE EUROPEAN SOCIETY OF CARDIOLOGY

STOCKHOLM – Healthy women who are first-degree relatives of patients with known familial dilated cardiomyopathy should be followed closely during pregnancy and the first 5 months postpartum for the emergence of life-threatening peripartum cardiomyopathy.

A significant subset of peripartum cardiomyopathy is the initial manifestation of familial dilated cardiomyopathy. Thus, when women with peripartum cardiomyopathy don’t fully recover left ventricular function, their first-degree family members should undergo screening for presymptomatic dilated cardiomyopathy, Dr. Karin Y. van Spaendonck-Zwarts said at the annual congress of the European Society of Cardiology.

Dr. van Spaendonck-Zwarts offered three lines of evidence in support of the hypothesis that a subset of peripartum cardiomyopathy is actually a first manifestation of familial dilated cardiomyopathy rather than, as previously assumed, a sporadic event.

One, in reviewing a Dutch cohort of 90 proven dilated cardiomyopathy families, she and her coinvestigators discovered five families, or 6%, had members with peripartum cardiomyopathy. This is far too high a figure to be due to chance. Peripartum cardiomyopathy is a rare disorder, with an estimated incidence in the United States of 1 case in 4,075 live births, noted Dr. van Spaendonck-Zwarts of University Medical Center, Groningen, The Netherlands.

Second, when the Dutch team reviewed their 10 most recent cases of peripartum cardiomyopathy, they found 3 of the 10 women did not show a full recovery of left ventricular ejection fraction and dimensions. Cardiologic screening of all first-degree relatives of these three women revealed previously undiagnosed cases of dilated cardiomyopathy in all three families.

Third, an in-depth genetic analysis conducted in one of the dilated cardiomyopathy families with a member who had peripartum cardiomyopathy revealed a mutation in TNNC1, the gene encoding cardiac troponin C. This supports the genetic nature of the disease in this particular case of peripartum cardiomyopathy.

"Together, these findings strongly suggest that a subset of peripartum cardiomyopathy is part of the spectrum of familial dilated cardiomyopathy presenting in the peripartum period," said Dr. van Spaendonck-Zwarts.

If the Dutch findings are confirmed elsewhere, the European Society of Cardiology classification of the cardiomyopathies may need to be amended. The ESC characterizes peripartum cardiomyopathy as a nonfamilial, nongenetic form of dilated cardiomyopathy, she observed.

Dr. van Spaendonck-Zwarts declared she has no relevant financial interests.

Recommended Reading

Better Survival Reported After EVAR Versus Open AAA Surgery
MDedge Internal Medicine
Hypertension, Cholesterol Are Largely Uncontrolled in U.S. Adults
MDedge Internal Medicine
Dose Adjustment of Enoxaparin in Burn Patients Studied
MDedge Internal Medicine
Cardiac Arrhythmia Incidence Hits 29% After Vascular Surgery
MDedge Internal Medicine
Obesity Is Global; Blood Pressure and Cholesterol, More Local
MDedge Internal Medicine
FDA Clears iPhone/iPad App
MDedge Internal Medicine
TNF Inhibitors for Psoriasis Linked to 48% Lower MI Risk
MDedge Internal Medicine
Trifurcation Technique Preserves Internal Iliac Flow After EVAR
MDedge Internal Medicine
Enhanced CPR May Improve Survival to Discharge
MDedge Internal Medicine
Predictors Identified for Psychological Outcomes in Children With Congenital Heart Interventions
MDedge Internal Medicine